Published in Obesity and Diabetes Week, October 23rd, 2006
The transaction, valued at approximately $33 million, has been approved by the boards of directors of both companies and is subject to German merger control clearance, which is expected shortly.
Through the combination of the expected proceeds from the Dia Real sale, the proceeds from the company's recently completed sale of...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Obesity and Diabetes Week